UPF3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.542800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.588200E-01
Normal-vs-Stage2
3.646000E-01
Normal-vs-Stage3
1.422000E-01
Normal-vs-Stage4
9.583400E-01
Stage1-vs-Stage2
2.364400E-01
Stage1-vs-Stage3
1.079430E-01
Stage1-vs-Stage4
9.935400E-01
Stage2-vs-Stage3
2.943600E-01
Stage2-vs-Stage4
3.234600E-01
Stage3-vs-Stage4
7.577600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.761200E-01
Normal-vs-AfricanAmerican
5.076600E-01
Normal-vs-Asian
3.495400E-01
Caucasian-vs-AfricanAmerican
9.823800E-01
Caucasian-vs-Asian
6.321200E-01
AfricanAmerican-vs-Asian
8.028800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.717600E-01
Normal-vs-Female
4.605000E-01
Male-vs-Female
4.359400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.243200E-01
Normal-vs-Age(41-60Yrs)
8.228400E-01
Normal-vs-Age(61-80Yrs)
1.974610E-01
Normal-vs-Age(81-100Yrs)
2.475200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.180000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.917000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.338200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.560180E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.995900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.303200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.807790E-01
Normal-vs-Daily Drinker
3.579800E-01
Normal-vs-Weekly Drinker
4.679800E-01
Normal-vs-Occasional Drinker
5.391600E-01
Normal-vs-Social Drinker
2.688800E-01
Non Drinker-vs-Daily Drinker
6.185200E-01
Non Drinker-vs-Weekly Drinker
5.164400E-01
Non Drinker-vs-Occasional Drinker
1.239440E-01
Non Drinker-vs-Social Drinker
5.757200E-01
Daily Drinker-vs-Weekly Drinker
8.484400E-01
Daily Drinker-vs-Occasional Drinker
3.794400E-01
Daily Drinker-vs-Social Drinker
9.571600E-01
Weekly Drinker-vs-Occasional Drinker
5.718600E-01
Weekly Drinker-vs-Social Drinker
8.822000E-01
Occasional Drinker-vs-Social Drinker
3.793400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.378000E-01
Normal-vs-Grade 2
9.500400E-01
Normal-vs-Grade 3
9.748800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.038000E-01
Grade 1-vs-Grade 3
5.226400E-01
Grade 1-vs-Grade 4
9.378000E-01
Grade 2-vs-Grade 3
5.421400E-01
Grade 2-vs-Grade 4
9.500400E-01
Grade 3-vs-Grade 4
9.748800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.948300E-02
Normal-vs-NonDiabetic
3.845000E-01
Diabetic-vs-NonDiabetic
2.536100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.981000E-01
Normal-vs-NoPancreatitis
2.435000E-01
Pancreatitis-vs-NoPancreatitis
7.677900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.665400E-01
Normal-vs-N1
4.027800E-01
N0-vs-N1
4.375400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.705000E-01
Normal-vs-TP53-NonMutant
4.888200E-01
TP53-Mutant-vs-TP53-NonMutant
7.659500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
